Anti-FAP T-cell engaging bispecific antibody for the treatment of pancreatic ductal adenocarcinoma

• Unité de recherche: INNOSUISSE
• Numéro de projet: 26686.1 PFLS-LS
• Titre du projet anglais: Anti-FAP T-cell engaging bispecific antibody for the treatment of pancreatic ductal adenocarcinoma

Description succincte (Allemand)

Anti-FAP T-cell engaging bispecific antibody for the treatment of pancreatic ductal adenocarcinoma

Description succincte (Anglais)

Résumé des résultats (Abstract) (Allemand)

MI201 is Mabimmune#s anti-FAP T-cell engaging bispecific antibody therapy. In this project MI201 will first be generated and tested for pre-clinical proof of efficacy. If successful, a safety and efficacy package for MI201 will be pursued to justify financing of human clinical trials.

Résumé des résultats (Abstract) (Anglais)